Skandinaviska Enskilda Banken (SEB)’s Ginkgo Bioworks DNA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-375	Closed	-$25K	–	904
2022 Q4	$25K	Hold	375	–	–	﹤0.01%	834
2022 Q3	$47K	Hold	375	–	–	﹤0.01%	857
2022 Q2	$36K	Hold	375	–	–	﹤0.01%	975
2022 Q1	$60K	Buy	375 +250	+200%	+$48.7K	﹤0.01%	947
2021 Q4	$45K	Hold	125	–	–	﹤0.01%	961
2021 Q3	$58K	Buy	+125	New	+$60.9K	﹤0.01%	977

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s DNA Position: Q1 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Ginkgo Bioworks (DNA) in Q1 2023, closing a stake of 375 shares — an estimated $25K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in DNA in Q3 2021 and held it in 6 quarters. The position peaked at $60K in Q1 2022. 313 funds tracked by Wall St. Rank hold DNA as of Q1 2023.

Skandinaviska Enskilda Banken (SEB) reported no remaining Ginkgo Bioworks position as of Q1 2023 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 375 Ginkgo Bioworks shares in Q1 2023, an estimated $25K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 6 quarters.
Skandinaviska Enskilda Banken (SEB)'s Ginkgo Bioworks position peaked at $60K in Q1 2022.
313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2023, filed 11 May 2023.